News

New genetic marker linked to improved survival with immunotherapy in ovarian and other cancers
Patients with ovarian clear cell carcinoma (OCCC) whose tumors have specific mutations in the PPP2R1A gene were found to have ...
Mirage News20h
Genetic Marker Boosts Immunotherapy Survival in Cancer
Patients with ovarian clear cell carcinoma (OCCC) whose tumors have specific mutations in the PPP2R1A gene were found to ...
Medscape2h
Efficacy and Toxicity Seen With MIRV in Platinum-Sensitive Ovarian Cancer
New PICCOLO trial analyses showed that mirvetuximab soravtansine achieved 52% response rates and 27-month overall survival in ...